Objective: Presently there is no clinically feasible imaging modality that can effectively detect cortical demyelination in patients with multiple sclerosis (MS). The objective of this study is to determine if clinically feasible magnetization transfer ratio (MTR) imaging is sensitive to cortical demyelination in MS.
Whole-brain MTR imaging is possible on most modern magnetic resonance (MR) systems at relatively high resolution without specialized sequences (unlike T1 and T2 relaxivity maps). Due to the conflicting results regarding the sensitivity of MTR to CL, we wanted to ascertain if MTR acquired under clinically feasible conditions would be sensitive to CL. To do so, we imaged the brains of deceased patients with MS in situ on a clinical MR system using acquisitions suitable for in vivo imaging, and compared mean normalized cortical MTR (normMTR ctx ) values in demyelinated and normally myelinated cortex.
METHODS Standard protocol approvals, registrations, and patient consents. These studies were approved by the Cleveland Clinic Institutional Review Board. Informed consent for participation was obtained either from the patient as an advance directive before death or from the next of kin after death.
Patients. Postmortem in situ brain imaging was performed and tissue was processed as described previously. 9 For this study, we analyzed brain MRI and tissue from 7 patients with MS (table) .
Postmortem in situ MRI. Postmortem in situ brain MRIs (figure 1) were acquired soon after death using a 3 T MR system (Tim Trio, Siemens, Erlangen, Germany). In 6 subjects, T1weighted (T1W) MRI were acquired with magnetization-prepared rapid acquisition gradient echo (repetition time [TR] 5 1,860 msec; echo time [TE] 5 2.8 msec; inversion time 5 1,100 msec; flip angle 5 10°; voxel size 5 0.94 3 0.94 3 0.94 mm 3 ; GRAPPA acceleration factor 5 2; acquisition time 5 4 minutes) and fast lowangle shot (TR 5 20 msec; TE 5 5 msec; flip angle 5 27°; voxel size 5 1 3 1 3 1 mm 3 ; acquisition time 5 9 minutes) sequences (in one subject, only FLASH was acquired). MTR was calculated from a pair of proton density-weighted gradient recalled echo volumes with/ without a magnetization transfer prepulse (MT ON and MT OFF : TR 5 24 msec; TE 5 3.81 msec; flip angle 5 10°; voxel size 5 1 3 1 3 1 mm 3 ; GRAPPA acceleration factor 5 2; acquisition time 5 4 minutes).
Registration of postmortem in situ MRI to fixed brain slices. After postmortem in situ MRI, the brain and spinal cord were removed, and one cerebral hemisphere was fixed in 4% paraformaldehyde for .9 weeks. After fixation, the hemisphere was reimaged in a custom-designed polycarbonate slicing box. 9 After postfixation MRI, the brain was sliced (1 cm coronal sections) within the box and photographed. The postmortem T1W MRI was registered to the postfixation MRI using rigid-body followed by affine transformations with FLIRT 10 ; in 4 of the cases, additional nonlinear registration was performed using FNIRT (http://www. fmrib.ox.ac.uk/fsl/fnirt/index.html). The equations of the brain slice planes (determined from MRI-visible markers on the slicing box indicating the positions of slots that guide slicing) were then used to extract the 2-dimensional postmortem MR images that corresponded to each fixed brain slice. The plane correspondence was compared with the photographs for gyral and sulcal features, and, if necessary, the equations of the planes were adjusted to achieve optimal correspondence between brain slice and postmortem MRI slice (figure 2, A and B).
Tissue sampling and proteolipid protein immunohistochemistry. Based on brain slice photographs, 89 tissue blocks sampling 6 cortical regions (frontal, parietal, occipital, temporal, insular, cingulate) were chosen for uniform, unbiased assessment. The blocks were cut (sized to fit a 22 3 40 mm 2 coverslip) and sectioned at 30 mm thick using a freezing-sliding microtome. Free-floating sections were immunostained for myelin using rat antiproteolipid protein (anti-PLP, gift from Dr. Wendy Macklin) by the avidinbiotin complex procedure with diaminobenzidine tetrahydrochloride as a chromagen. 11 Each PLP-stained section was examined for demyelination at 103 using a Zeiss Axiophot light microscope (Carl Zeiss Micro-Imaging, LLC, Thornwood, NY). The cortex was classified by an observer blinded to the MRI results as one of the following: mostly myelinated (MM ctx ), in which more than half of the cortex had normal PLP staining, and there were no large regions of complete demyelination (figure 3C); mostly demyelinated (MD ctx ), in which more than half of the cortex features little or no PLP staining extending at least 1 mm deep from the pial surface with no large regions of normal-appearing cortex (figure 3D); or intermediately demyelinated (ID ctx ), which may feature patches of normal-appearing cortex, demyelinated cortex, or regions of low myelin density ( figure 3E ). Remyelination was not assessed.
Calculating mean normalized cortical MTR. The uncorrected MT OFF and MT ON were transformed to correspond with the postmortem T1W MRI. The MTR map was calculated (100 3 [MT OFF 2 MT ON ]/MT OFF ) and transformed to correspond with the fixed brain slices ( figure 2D ).
The cortex corresponding to each cortical section was manually segmented on the MRIs by an observer blinded to the immunostaining results who referred to photographs of the unstained tissue blocks; the intensity-normalized 12 MT OFF was used to visually define the brain surface/CSF interface and the intensitynormalized 12 T1W MRI was used to define the cortex/WM interface. Normal-appearing WM proximate to the segmented cortex was also manually segmented on the T1W MRI. This procedure was considered to be adequately unbiased as the observer was blinded to PLP staining and MTR that were compared in the statistical analyses.
For each cortical region, the mean cortical MTR (MTR ctx ) was calculated from the MTR values of the segmented cortex, if these values were normally distributed according to the Lilliefors or Jarque-Bera tests (MATLAB, R2009a, The Mathworks, Inc., Natick, MA). MTR values within each cortical region were presumed to be normally distributed under the assumption that the underlying tissue composition is uniform, with the exception of relatively small foci (foci much smaller than the 1 mm 3 voxel volume are undetectable). If the MTR values of the segmented cortex did not satisfy either normality test, outlying values (starting with values ,2.5th percentile or .97.5th percentile) were iteratively omitted until one of the tests was satisfied; the mean MTR ctx was then calculated from the truncated distribution, which contained data from an average of 59 voxels/region. Outliers were eliminated because we believed that they corresponded to isolated voxels of normal or demyelinated WM, CSF, partial volume, or artifact (the exact composition of the outlier voxels cannot be determined from the PLP-stained slides, since the exact positioning of the voxels with respect to the slide is not known and the slides display only 0.03-mm-thick tissue sections, whereas the MRI is sensitive to 1-mm-thick tissue). The median value of the percentage of voxels eliminated was 0%/region; 85% of regions had no voxels eliminated. For the regions where voxels were eliminated, median value of the percentage of voxels eliminated was 10%/region. To standardize the mean MTR ctx values over different cortical regions and subjects, we normalized the mean MTR ctx of each region by dividing by the subject's overall mean WM MTR of all selected normal-appearing WM voxels within the subject's brain. The percent coefficient of variation of the overall mean WM MTR of the subjects was 2.8%, suggesting that it is a relatively stable value and suitable to use for normalization.
Statistics. A linear mixed-effects model (JMP, Release 8, SAS
Institute Inc., Cary, NC) within the "Fit Model" platform fitted with the restricted maximum likelihood method was used to test for a significant effect of cortical myelin status classification on mean normMTR ctx . Mean normMTR ctx was the response variable, myelin status classification was a fixed model effect, and subject within myelin status classification was a random effect. To determine if mean normMTR ctx is significantly lower in demyelinated cortex, myelin status was coded "0" for MM ctx and "1" for ID ctx and MD ctx . To determine if mean normMTR ctx is significantly different for each myelin status class, each class was coded separately and a Tukey-Kramer honestly significant difference (Tukey HSD) test was used to determine if comparisons of myelin status classes yielded significant differences in mean normMTR ctx .
RESULTS MRI and histopathology were performed on the brains of 7 patients with MS (see table) : mean age 5 65 years (SD 5 10 years); mean disease duration 5 29 years (SD 5 12 years); mean death-to-MRI interval 5 4 hours (SD 5 1 hour). Eighty-nine tissue blocks were examined (mean 5 13 blocks/ brain, range 5 9-19 blocks/brain). Based on PLP immunostaining, 45 tissue sections were classified as MM ctx , 17 were classified as MD ctx , and 27 were classified as ID ctx . All CL observed were subpial or intracortical. All patients had cortical regions that featured some demyelination (ID ctx or MD ctx ). In one of the patients, all of the sections featured some demyelination.
Using the linear mixed-effects model that combined ID ctx and MD ctx into one group, we found that mean normMTR ctx was significantly lower in demyelinated cortex (ID ctx or MD ctx ) compared to MM ctx (demyelinated cortex: least-squares mean [LSM] 5 0.797, SE 5 0.007; MM ctx : LSM 5 0.837, SE 5 0.006; p 5 0.01, n 5 89) ( figure 4 ). The 2 lowest outlying MM ctx values likely result from cortex/CSF partial-volume effect, since the corresponding regions were situated in locations of pronounced cortical convolution (superior frontal cortex in the most anterior coronal brain slice and inferior occipital cortex).
The linear mixed-effects model analysis that considered each myelin status class separately revealed a significant effect of myelin status classification on mean normMTR ctx (p 5 0.01). The Tukey HSD test indicated that mean normMTR ctx was significantly different in MD ctx compared to MM ctx , but the mean normMTR ctx was not significantly different in ID ctx when it was compared to MD ctx or MM ctx .
Testing the myelin status classification reproducibility by repeating the classification after ;104 days revealed the following: 1% of the sections were reclassified from MD ctx to ID ctx , 2% were reclassified from ID ctx to MM ctx , and there were no significant changes to the results of the statistical tests. Testing the cortical segmentation reproducibility by repeating [13] [14] [15] [16] In primary progressive MS, MTR ctx reductions were associated with disability. 15 In these in vivo studies, the pathologic substrate of reduced MTR is unknown. Postmortem MRI/ histopathology studies offer the opportunity to understand the pathology underlying in vivo imaging-related observations. It is often suggested that decreased MTR ctx in patients with MS arises due to CL; however, postmortem MRI/histopathology correlation studies have not agreed on the sensitivity of MTR to CL. In this study we wanted to ascertain whether MTR acquired within a clinical setting would be sensitive to cortical demyelination. To do so, we imaged postmortem brains in situ on a 3 T clinical MR system using clinically feasible imaging sequences, including conventional MRI and MRI for MTR calculation, and compared mean normMTR ctx values in demyelinated and normally myelinated cortex. We found that mean normMTR ctx was significantly lower in demyelinated cortex compared to MM ctx . The presence of CL in patients with MS has been recognized for more than 5 decades. 1, 2 In this study we found that all patients had cortical regions with some demyelination, which is consistent with early findings. 2 The high percentage of affected patients in this study may be due to the fact that all of the patients had been diagnosed with progressive MS, which has been shown to feature a higher percentage of demyelinated cortex compared to acute MS. 17 Despite the prevalence of CL on immunostained postmortem brain, the vast majority of these lesions are not visible on typical clinically feasible MRI. The findings of previous studies that MTR at 1.5 T with a voxel size of 5 mm 3 was not sensitive to cortical demyelination, 7 but was sensitive at 9.4 T, 8 suggest that a field strength .1.5 T and a voxel size ,5 mm 3 may be necessary to detect cortical lesions. Our results support this notion, as we demonstrated that MTR at 3 T with a voxel size of 1 mm 3 reveals significant differences between demyelinated and normalappearing cortex. The benefit of higher field is likely due to the improvement in signal-to-noise and contrast-to-noise of the MTR. 18 T1 and T2 relaxation rates have been found to be significantly different between demyelinated and normally myelinated cortex on images obtained from ex vivo brain slices at 1.5 T 7 ; at 9.4 T, the significant effect was found for T2 but not for T1. 8 We could not evaluate the sensitivity of T1 and T2 relaxivity to CL, as the sequences are not standard for clinical use and not included in our MRI protocol. In contrast to quantitative T1 and T2 mapping, the sequences for MTR calculation used in this study can be directly transitioned to clinical practice without need for pulse sequence programing.
At 3 T, we found a difference of 5% between mean normMTR ctx of MM ctx and demyelinated cortex. Previously reported differences between myelinated and demyelinated MTR ctx in ex vivo tissues were 5% at 1.5 T 7 and 19% at 9.4 T. 8 There are a few reasons why we expect a smaller percentage difference between myelinated and demyelinated MTR ctx in our study compared to the 9.4 T study: 1) the mean normMTR ctx was calculated over the entire PLP-immunostained cortical region (containing both normal and demyelinated cortex) and not only in small purely myelinated or demyelinated regions; 2) the contrast-to-noise ratio at 3 T is expected to be lower than at 9.4 T; 3) the 1 mm 3 voxel size in this study is much larger (more susceptible to partialvolume effects) than the voxel size used at 9.4 T.
Although we found that mean normMTR ctx was significantly different in MD ctx compared to MM ctx , there was no significant difference when ID ctx was compared to either MD ctx or MM ctx . The lack of sensitivity of mean normMTR ctx to ID ctx may be due to inherent limitations of the comparison between MRI-derived and histopathologically derived metrics under our experimental conditions. The MRIderived metric, mean normMTR ctx , represents an average over 1 mm 3 cortical voxels within a 1-mm-thick region, while the histopathologically derived metric, MM ctx /ID ctx /MD ctx , represents the cortical myelin status classification of a 0.03-mm-thick section most closely corresponding to the MRI. In cortical regions that are uniformly normally myelinated or demyelinated, it is reasonable to expect that mean normMTR ctx would accurately reflect the myelin status classification, which is supported by the significant differences in mean normMTR ctx that we observed when comparing MM ctx and MD ctx . The within-class mean normMTR ctx dispersion likely arises due to myelin density heterogeneity within the 1-mm-thick regions (e.g., some cortical regions may be mostly demyelinated in the 0.03-mm-thick PLP-stained tissue section but mostly normally myelinated in the rest of the MRI-detected 1-mm-thick region, resulting in a relatively high mean normMTR ctx in a region classified as demyelinated). It is also reasonable to expect that the mean normMTR ctx calculated over many 1-mm 3 voxels may not be sensitive to relatively small foci of demyelinated cortex observed on sections classified as ID ctx .
In the absence of tissue pathology, MTR values may vary over different cortical regions within a single brain and between different brains. One of the largest contributors to MTR variability is B 1 field non uniformity. [18] [19] [20] To minimize the effect of MTR variations between different brains on MTR sensitivity to cortical demyelination, we normalized the mean MTR ctx of each region using the subject's overall mean WM MTR. The mean normMTR ctx in MM ctx spanned the range of values inferred from published values. 21 The normalization may be expected to decrease the sensitivity to cortical demyelination if the mean WM MTR was low in subjects with many regions of cortical demyelination and high in subjects with many regions of normally myelinated cortex. We did not find large variations in mean WM MTR between subjects.
Although our results demonstrate that clinically feasible MTR is sensitive to cortical demyelination, there are limitations to this study. Our results are based on postmortem imaging, which is free of motion artifacts that may be observed on in vivo MRI and may be expected to affect the sensitivity of any imaging modality to pathology. The brains examined in this study were from patients with MS with a relatively long disease course, and therefore we are not able to determine if the mean normMTR ctx is also significantly lower in early-stage MS CL that may feature inflammation. 22 In this study, as in other studies of the sensitivity of semiquantitative or quantitative MRI to CL, we classified myelin status rather than quantifying the degree of demyelination. This approach precludes estimation of the correlation between mean normMTR ctx and degree of cortical demyelination, which would have been compromised by the MRI-derived metric sampling a thicker tissue region than the PLP-stained tissue section. In spite of this weakness, we were able to demonstrate that mean normMTR ctx is sensitive to cortical demyelination, perhaps even when as little as 2.5% of the cortical area is demyelinated, which we found in a simplistic analysis in which the relative amount of demyelinated cortex was estimated from the PLP-immunostained slides. We recognize that mean normMTR ctx alone cannot be used to prospectively identify CL, and suggest that prospective detection of CL may be achieved using a quantitative multimodal approach that includes MTR ctx , since visual assessment of any single MRI modality has not proven to be adequately sensitive. Future postmortem 3 T MRI/histopathology studies should include acquisitions to calculate T1 and T2 relaxation rates in addition to MTR, and additional immunostaining should be performed to evaluate both sensitivity and specificity to CL. An important confounding factor of using MTR to evaluate WM demyelination is inflammation, and CL have been shown to exhibit little inflammation; therefore we may presume that low MTR ctx may be relatively specific to cortical demyelination. The above-mentioned limitations do not weaken our finding that clinically feasible MTR is sensitive to cortical demyelination. We propose that advanced image processing methods can be developed to automatically detect abnormally low MTR measurements consistent with CL, enabling the quantification of cortical lesion load and distribution in living patients with MS.
